PDF (2.8 MB)
Collect
Submit Manuscript
Research Article | Open Access

Exploring urban versus rural disparities in atrial fibrillation: prevalence and management trends among elderly Chinese in a screening study

Wei ZHANG1Yi CHEN1Lei-Xiao HU1Jia-Hui XIA1Xiao-Fei YE1Wen-Yuan-Yue WANG1Xin-Yu WANG1Quan-Yong XIANG2Qin TAN3Xiao-Long WANG4Xiao-Min YANG5De-Chao ZHAO6Xin CHEN1Yan LI1Ji-Guang WANG1,7() for the IMPRESSION Investigators and Coordinators
Department of Cardiovascular Medicine, Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Department of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Department of Chronic Non-communicable Disease Control, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China
Shanghai Pudong New Area Sanlinkangde Community Health Center, Shanghai, China
Department of Cardiology, People's Hospital of Hongsibao District, Ningxia, China
General Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Zhejiang, China
Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin, China
National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Show Author Information

Abstract

BACKGROUND

Atrial fibrillation (AF) is a common cardiac arrhythmia in the elderly. This study aimed to evaluate urban-rural disparities in its prevalence and management in elderly Chinese.

METHODS

Consecutive participants aged ≥ 65 years attending outpatient clinics were enrolled for AF screening using handheld single-lead electrocardiogram (ECG) from April 2017 to December 2022. Each ECG rhythm strip was reviewed from the research team. AF or uninterpretable single-lead ECGs were referred for 12-lead ECG. Primary study outcome comparison was between rural and urban areas for the prevalence of AF. The Student’s t-test was used to compare mean values of clinical characteristics between rural and urban participants, while the Pearson’s chi-square test was used to compare between-group proportions. Multivariate stepwise logistic regression analysis was performed to estimate the association between AF and various patient characteristics.

RESULTS

The 29,166 study participants included 13,253 men (45.4%) and had a mean age of 72.2 years. The 7073 rural participants differed significantly (P ≤ 0.02) from the 22,093 urban participants in several major characteristics, such as older age, greater body mass index, and so on. The overall prevalence of AF was 4.6% (n = 1347). AF was more prevalent in 7073 rural participants than 22,093 urban participants (5.6% vs. 4.3%, P < 0.01), before and after adjustment for age, body mass index, blood pressure, pulse rate, cigarette smoking, alcohol consumption and prior medical history. Multivariate logistic regression analysis identified overweight/obesity (OR = 1.35, 95% CI: 1.17–1.54) in urban areas and cigarette smoking (OR = 1.62, 95% CI: 1.20–2.17) and alcohol consumption (OR = 1.42, 95% CI: 1.04–1.93) in rural areas as specific risk factors for prevalent AF. In patients with known AF in urban areas (n = 781) and rural areas (n = 338), 60.6% and 45.9%, respectively, received AF treatment (P < 0.01), and only 22.4% and 17.2%, respectively, received anticoagulation therapy (P = 0.05).

CONCLUSIONS

In China, there are urban-rural disparities in AF in the elderly, with a higher prevalence and worse management in rural areas than urban areas. Our study findings provide insight for health policymakers to consider urban-rural disparity in the prevention and treatment of AF.

Electronic Supplementary Material

Download File(s)
JGC-202408-025-R1-Supplemental.pdf (832.3 KB)

References

[1]

Elliott AD, Middeldorp ME, Van Gelder IC, et al. Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol 2023; 20: 404−417.

[2]

Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013; 34: 2746−2751.

[3]

Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013; 112: 1142−1147.

[4]

Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149: 657−663.

[5]

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42: 373−498.

[6]

Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272, 186 patients hospitalized with incident atrial fibrillation 1995-2008: Swedish nationwide long-term case-control study. Eur Heart J 2013; 34: 1061−1067.

[7]

Sepehri Shamloo A, Dagres N, Müssigbrodt A, et al. Atrial fibrillation and cognitive impairment: new insights and future directions. Heart Lung Circ 2020; 29: 69−85.

[8]

Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patient with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492−501.

[9]

Freedman B, Hindricks G, Banerjee A, et al. World Heart Federation roadmap on atrial fibrillation: a 2020 update. Glob Heart 2021; 16: 41.

[10]

Shi S, Tang Y, Zhao Q, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study. Lancet Reg Health West Pac 2022; 23: 100439.

[11]

Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012-2015. Circulation 2018; 137: 2344−2356.

[12]

Yu Q, Lin S, Wu J. Hypertension prevalence rates among urban and rural older adults of China, 1991-2015: a standardization and decomposition analysis. Front Public Health 2021; 9: 713730.

[13]

Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: cross-sectional study. Lancet 2012; 379: 805−814.

[14]

Chei CL, Raman P, Ching CK, et al. Prevalence and risk factors of atrial fibrillation in Chinese elderly: results from the Chinese Longitudinal Healthy Longevity Survey. Chin Med J (Engl) 2015; 128: 2426−2432.

[15]

Wang Z, Chen Z, Wang X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey. Am J Cardiol 2018; 122: 793−798.

[16]

Zhang W, Chen Y, Huang Q, et al. Rationale and design of randomized controlled trial on Intensive Management of blood PRESSure and cholesterol in elderly Chinese with hypertension and atrial fibrillatION (IMPRESSION). Cardiol Discov 2021; 1: 173−178.

[17]

Wang X, Fu Q, Song F, et al. Prevalence of atrial fibrillation in different socioeconomic region of China and its association with stroke: results from a national stroke screening survey. Int J Cardiol 2018; 271: 92−97.

[18]

Soni A, Earon A, Handorf A, et al. High burden of unrecognized atrial fibrillation in rural India: an innovative community-based cross-sectional screening program. JMIR Public Health Surveill 2016; 2: e159.

[19]

Al-Khatib SM, Allen LaPointe NM, Chatterjee R, et al. Rate-and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med 2014; 160: 760−773.

[20]

Mkoko P, Bahiru E, Ajijola OA, et al. Cardiac arrhythmias in low- and middle-income country. Cardiovasc Diagn Ther 2020; 10: 350−360.

[21]

Chen M, Li C, Liao P, et al. Epidemiology, management, and outcomes of atrial fibrillation among 30 million citizens in Shanghai, China from 2015 to 2020: a medical insurance database study. Lancet Reg Health West Pac 2022; 23: 100470.

[22]

Xia Z, Dang W, Jiang Y, et al. Association between atrial fibrillation and the risk of cardiovascular mortality among elderly adults with ischemic stroke in northeast China: a community-based prospective study. Front Aging Neurosci 2022; 14: 836425.

[23]

Ben Freedman S, Gersh BJ, Lip GY. Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation. Eur Heart J 2015; 36: 653−656.

[24]

Vinereanu D, Lopes RD, Bahit MC, et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 2017; 390: 1737−1746.

[25]

Zhang M, Wu J, Zhang X, et al. [Prevalence and control of hypertension in adults in China, 2018]. Chin J Epidemiol 2021; 42: 1780−1789. [In Chinese].

[26]

Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of national survey. BMJ 2023; 380: e071952.

[27]

Lee SR, Park CS, Choi EK, et al. Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study. Hypertension 2021; 77: 919−928.

[28]

Lee SR, Choi YJ, Choi EK, et al. Blood pressure variability and incidence of new-onset atrial fibrillation: a nationwide population-based study. Hypertension 2020; 75: 309−315.

[29]

Chen Y, Zhang W, Sheng CS, et al. A prospective study on the association between atrial fibrillation and blood pressure in an elderly Chinese population. Int J Cardiol 2023; 372: 113−119.

Journal of Geriatric Cardiology
Pages 246-254
Cite this article:
ZHANG W, CHEN Y, HU L-X, et al. Exploring urban versus rural disparities in atrial fibrillation: prevalence and management trends among elderly Chinese in a screening study. Journal of Geriatric Cardiology, 2025, 22(2): 246-254. https://doi.org/10.26599/1671-5411.2025.02.001
Metrics & Citations  
Article History
Copyright
Rights and Permissions
Return